Using a blood test to reduce antibiotics in preterm newborns
Treatments studied
Part of Genetic & congenital, Infections clinical trials.
This study checks if a blood test (presepsin) can help doctors safely stop antibiotics earlier in preterm babies at moderate risk of infection. The goal is to reduce unnecessary antibiotic use.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your baby must be born between 24 weeks and 31 weeks and 6 days of pregnancy.
- Your baby must have a moderate risk of early infection, meaning doctors would start antibiotics based on the Dutch guideline.
- Your baby cannot be at low risk (no antibiotics needed) or high risk (signs of serious infection).
- High risk includes conditions like mother having sepsis, need for strong breathing support, or unstable blood pressure requiring medicine.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares giving antibiotics to all preterm babies at risk of infection versus giving them only if symptoms develop. It aims to find out if waiting is safer and reduces unnecessary antibiotic use.
This trial tests a new, faster way to find bacteria in the blood of children with suspected sepsis. It uses a molecular test that may give results sooner than standard cultures, helping doctors treat infections more quickly.
This trial is testing ways to make the best treatment decisions for newborns who may have an early infection (sepsis). It focuses on babies born at 34 weeks or later and within their first three days of life.
This study is testing a new blood test to see if it can help doctors decide when to use antibiotics for newborns who may have a late-onset infection. The goal is to reduce unnecessary antibiotic use.
This study looks at whether a blood test called presepsin can help doctors diagnose sepsis (a serious infection) in newborn babies. If it works, it could help doctors start treatment faster and more accurately.
This study tests whether giving an early antibiotic (meropenem) based on a new blood test (PSP) can prevent serious infections (sepsis) in people who come to the emergency department with signs of infection. The goal is to find out if this approach helps them get better faster and avoid more severe illness.
Hear when a new Early-Onset Neonatal Sepsis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.